KRISTEN PRICE: Open Payments
NPI 1417497918 · YANCEYVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 10 payments from 9 companies in 2025. Trend: 2023 $187 · 2024 $165 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $41 |
| Gilead Sciences, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: Wegovy, REXULTI, Kerendia, INGREZZA, AUSTEDO XR, CAPLYTA, PURIFIED CORTROPHIN GEL, FANAPT.
Industry payments across NC — which companies pay providers there.
